Q2 Sales growth at aap 47% according to preliminary Figures


According to analysis of preliminary figures, aap Implantate AG, a medical technology company active in the fields of biomaterials and implants for trauma and joint reconstruction, chalked up EUR 4.7 million in sales in the second quarter of 2006. That was equivalent to 47% year-on-year growth (previous year: EUR 3.2 million). Adjusted for acquisitions, organic sales growth was 43%. In the first half of 2006, aap Group sales totaled EUR 9.1 million and thereby exceeded the H1 2005 total of EUR 6.3 million by 44% (growth adjusted for acquisitions: 41%).

Publication of the full aap Implantate AG report for the second quarter of 2006 is scheduled for August 2, 2006.